Cormorant Asset Management, LP - 10%+ Owner at EyePoint Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

Cormorant Asset Management, LP - trading volume in the past year for EyePoint Pharmaceuticals, Inc.

Holdings reported by Cormorant Asset Management, LP for EyePoint Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8.33M $103M $12.36 May 6, 2024 Indirect

Transactions reported by Cormorant Asset Management, LP for EyePoint Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.